Polyphenols: a Promising Nutritional Approach to Prevent or Reduce the Progression of Prehypertension

被引:28
作者
Davinelli S. [1 ]
Scapagnini G. [1 ]
机构
[1] Department of Medicine and Health Sciences, University of Molise, Via De Sanctis snc, Campobasso
关键词
Diet; Polyphenols; Prehypertension; Prevention;
D O I
10.1007/s40292-016-0149-0
中图分类号
学科分类号
摘要
Diet plays a crucial role in maintaining healthy blood pressure. Functional foods are increasingly popular among health-conscious consumers to reduce cardiovascular risk factors and improve vascular health. In particular, dietary polyphenols represent an extraordinary inventory of structurally different compounds that may represent promising candidate chemical entities to prevent or delay the onset of hypertension. In recent years, it has been recognized that prehypertension may be a predictor of clinical hypertension and consequently of cardiovascular risk. Moreover, prehypertension status is associated with increased levels of several inflammatory markers and it is also characterized by structural changes, including endothelial dysfunction and arteriolar hypertrophy. Despite the low bioavailability of polyphenols and the lack of clinical data from nutritional intervention studies, the antihypertensive role of polyphenols to control blood pressure and reduce inflammation and endothelial dysfunction has been subject of recent debate. The purpose of this article is to discuss the potential benefits of dietary polyphenols as a promising and effective nutritional strategy for the management of prehypertension. © 2016, Springer International Publishing Switzerland.
引用
收藏
页码:197 / 202
页数:5
相关论文
共 57 条
[1]  
Rothwell P.M., Does blood pressure variability modulate cardiovascular risk?, Curr Hypertens Rep, 13, pp. 177-186, (2011)
[2]  
Webb A.J., Fischer U., Mehta Z., Rothwell P.M., Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis, Lancet, 375, pp. 906-915, (2010)
[3]  
Muntner P., Shimbo D., Tonelli M., Reynolds K., Arnett D.K., Oparil S., The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994, Hypertension, 57, pp. 160-166, (2011)
[4]  
Parati G., Ochoa J.E., Bilo G., Blood pressure variability, cardiovascular risk, and risk for renal disease progression, Curr Hypertens Rep, 14, pp. 421-431, (2012)
[5]  
Parati G., Ochoa J.E., Lombardi C., Bilo G., Assessment and management of blood-pressure variability, Nat Rev Cardiol., 10, pp. 143-155, (2013)
[6]  
Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Roccella E.J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure, Hypertension, 42, pp. 1206-1252, (2003)
[7]  
Vasan R.S., Larson M.G., Leip E.P., Kannel W.B., Levy D., Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham heart study: a cohort study, Lancet, 358, pp. 1682-1686, (2001)
[8]  
Greenlund K.J., Croft J.B., Mensah G.A., Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999–2000, Arch Intern Med, 164, pp. 2113-2118, (2004)
[9]  
Qureshi A.I., Suri M.F., Kirmani J.F., Divani A.A., Mohammad Y., Is prehypertension a risk factor for cardiovascular diseases?, Stroke, 36, pp. 1859-1863, (2005)
[10]  
Liszka H.A., Mainous A.G., King D.E., Everett C.J., Egan B.M., Prehypertension and cardiovascular morbidity, Ann Fam Med., 3, pp. 294-299, (2005)